Skip to main content

Peer Review reports

From: SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen

Original Submission
22 Mar 2023 Submitted Original manuscript
4 May 2023 Reviewed Reviewer Report - Kirsty Loudon
7 Jun 2023 Author responded Author comments - Lilibeth Arias
Resubmission - Version 2
7 Jun 2023 Submitted Manuscript version 2
Publishing
10 Jun 2023 Editorially accepted
28 Jun 2023 Article published 10.1186/s13063-023-07448-0

You can find further information about peer review here.

Back to article page